
Back to articles | Analysis | Stocks
NGFO six-month profit rose 10.2-fold and P/E of 5.12 is below half its sector, but October scrap rose 27% versus 14% for sheet; Sahmino target 14,014 rials (November 3, 2026)
Sahmino Research Desk | 3 November 2026 | 12 min read
NGFO's standalone net profit reached 9,437 billion rials in the six months to September 22, 2026, 10.2 times a year earlier, with gross margin rising from 7.4% to 18.7%. In October scrap purchases cost 27.1% more and sheet sold for 14.1% more than in September. November 2 close: 12,720 rials, P/E 5.12 versus sector 10.86. Sahmino's desk: target…
Related video
References
- Codal | Securities and Exchange Organization of IranTracking 1617512: standalone interim statements for six months to 22 September 2026 (unaudited): revenue 50,647,864, gross profit 9,478,609, net profit 9,436,627 and net operating cash flow 7,785,945 million rials.Cited Nov 3, 2026
- Codal | Securities and Exchange Organization of IranTracking 1621419: monthly activity report for the month to 22 October 2026; domestic sheet rate 956,247,217 rials per tonne; scrap purchases of 12,975 tonnes at 677,674,220 rials per tonne.Cited Nov 3, 2026
- Codal | Securities and Exchange Organization of IranTracking 1618134 (corrected): monthly activity report for the month to 22 September 2026; domestic sales 64,698 tonnes and exports 1,592 tonnes year to date; September sheet rate 837,728,276 and scrap rate 533,136,409 rials per tonne.Cited Nov 3, 2026
- SahminoNGFO: buy stance for the session of 2 November 2026, reference 12,720, target 14,013.52, invalidation 12,472.97 rials, horizon 15 sessions; 2 November close 12,720 rials; board reading at 17:34 on 3 November, revisable close 12,800 rials.Cited Nov 3, 2026
Related articles
- SHHZ's six-month operating cash covered 2.6% of profit versus 89.5% on a restated trailing year; Sahmino's invalidation is 3,080 rials (November 1, 2026)
- Pakshoo's six-month profit rises 3.5 times while operating cash turns negative; Sahmino targets 15,637 rials (October 22, 2026)
- KRSH Stands 17.7% Below Its 4 October High as Half-Year Profit Rises 3.8x but Latest Monthly Sales Fall 8.3% (4 November 2026)
- Farabi Pharma's Six-Month Profit Passed Its Whole Prior Year, but Operating Cash Is 37.6% of Profit; Entry Holds Up to 21,273 Rial (Monday 2 November 2026)




